ArticleArabian journal of chemistry2020

TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19.

Mohammad Azam Ansari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.